Equels Thomas K
SEC CIK 1450324 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| AIM | AIM ImmunoTech Inc. | CEO, Pres, Dir | 126.8K | $323.7K | — | 38 | 2021-07-16 | 2026-09-17 |
Most active insiders at AIM, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Equels Thomas K | CEO, Pres, Dir | $13.5K | — |
| 2 | CHEMEROW DAVID I. | Dir | — | — |
Transactions 38
Purchase Sale Sale after option exercise All abbreviations
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-09-18 08:30 | 2026-09-17 | AIM | AIM ImmunoTech Inc. | Equels Thomas K | CEO, Pres, Dir | P - Purchase | $0.208 | +24.0K | 126.8K | +23% | +$4,992 | |
| 2026-09-17 12:01 | 2026-09-16 | AIM | AIM ImmunoTech Inc. | Equels Thomas K | CEO, Pres, Dir | P - Purchase | $0.21 | +11.0K | 102.8K | +12% | +$2,310 | |
| 2026-09-16 09:15 | 2026-09-15 | AIM | AIM ImmunoTech Inc. | Equels Thomas K | CEO, Pres, Dir | P - Purchase | $0.221 | +22.0K | 91.8K | +32% | +$4,862 | |
| 2026-09-15 16:30 | 2026-09-14 | AIM | AIM ImmunoTech Inc. | Equels Thomas K | CEO, Pres, Dir | P - Purchase | $0.219 | +5,900 | 69.8K | +9% | +$1,292 | |
| D | 2026-03-16 | 2026-03-12 | AIM | AIM ImmunoTech Inc. | Equels Thomas K | CEO, Pres, Dir | C - Cnv Deriv | $0.00 | +25.0K | 63.9K | +64% | $0 |
| 2025-06-16 | 2025-06-13 | AIM | AIM ImmunoTech Inc. | Equels Thomas K | CEO, Pres, Dir | P - Purchase | $7.70 | +107 | 38.9K | +0.3% | +$823.90 | |
| 2025-06-13 | 2025-06-12 | AIM | AIM ImmunoTech Inc. | Equels Thomas K | CEO, Pres, Dir | P - Purchase | $8.70 | +103 | 38.7K | +0.3% | +$896.10 | |
| 2025-04-23 | 2025-04-11 | AIM | AIM ImmunoTech Inc. | Equels Thomas K | CEO, Pres, Dir | P - Purchase | $0.03 | +1.97M | 3.87M | +104% | +$59.1K | |
| 2025-04-07 | 2025-04-04 | AIM | AIM ImmunoTech Inc. | Equels Thomas K | CEO, Pres, Dir | P - Purchase | $0.06 | +41.0K | 1.90M | +2% | +$2,460 | |
| 2025-03-06 | 2025-03-05 | AIM | AIM ImmunoTech Inc. | Equels Thomas K | CEO, Pres, Dir | P - Purchase | $0.13 | +50.0K | 1.86M | +3% | +$6,500 | |
| 2025-03-05 | 2025-03-04 | AIM | AIM ImmunoTech Inc. | Equels Thomas K | CEO, Pres, Dir | P - Purchase | $0.12 | +44.0K | 1.81M | +2% | +$5,280 | |
| 2025-03-04 | 2025-03-04 | AIM | AIM ImmunoTech Inc. | Equels Thomas K | CEO, Pres, Dir | P - Purchase | $0.12 | +83.3K | 1.76M | +5% | +$10.0K | |
| 2025-01-21 | 2024-11-21 | AIM | AIM ImmunoTech Inc. | Equels Thomas K | CEO, Pres, Dir | P - Purchase | $0.21 | +20.0K | 1.66M | +1% | +$4,200 | |
| 2024-12-19 | 2024-12-18 | AIM | AIM ImmunoTech Inc. | Equels Thomas K | CEO, Pres, Dir | P - Purchase | $0.21 | +22.7K | 1.68M | +1% | +$4,773 | |
| 2024-11-21 | 2024-11-20 | AIM | AIM ImmunoTech Inc. | Equels Thomas K | CEO, Pres, Dir | P - Purchase | $0.2 | +85.0K | 1.64M | +5% | +$17.0K | |
| 2024-11-20 | 2024-11-20 | AIM | AIM ImmunoTech Inc. | Equels Thomas K | CEO, Pres, Dir | P - Purchase | $0.18 | +60.1K | 1.55M | +4% | +$10.8K | |
| 2024-09-17 | 2024-09-16 | AIM | AIM ImmunoTech Inc. | Equels Thomas K | CEO, Pres, Dir | P - Purchase | $0.3 | +5,000 | 1.49M | +0.3% | +$1,500 | |
| 2024-09-16 | 2024-09-13 | AIM | AIM ImmunoTech Inc. | Equels Thomas K | CEO, Pres, Dir | P - Purchase | $0.31 | +20.0K | 1.49M | +1% | +$6,200 | |
| 2024-09-12 | 2024-09-11 | AIM | AIM ImmunoTech Inc. | Equels Thomas K | CEO, Pres, Dir | A - Grant | $0.32 | +312.5K | 1.47M | +27% | +$100.0K | |
| 2024-08-12 | 2024-08-12 | AIM | AIM ImmunoTech Inc. | Equels Thomas K | CEO, Pres, Dir | A - Grant | $0.27 | +377.4K | 1.16M | +48% | +$101.9K | |
| 2024-05-07 | 2024-05-06 | AIM | AIM ImmunoTech Inc. | Equels Thomas K | CEO, Pres, Dir | P - Purchase | $0.41 | +61.7K | 778.2K | +9% | +$25.3K | |
| 2024-03-18 | 2024-03-15 | AIM | AIM ImmunoTech Inc. | Equels Thomas K | CEO, Pres, Dir | P - Purchase | $0.33 | +75.8K | 716.5K | +12% | +$25.0K | |
| 2023-11-27 | 2023-11-27 | AIM | AIM ImmunoTech Inc. | Equels Thomas K | CEO, Pres, Dir | P - Purchase | $0.44 | +33.9K | 640.7K | +6% | +$14.9K | |
| 2023-09-29 | 2023-09-29 | AIM | AIM ImmunoTech Inc. | Equels Thomas K | CEO, Pres, Dir | P - Purchase | $0.44 | +22.7K | 606.8K | +4% | +$9,977 | |
| 2023-08-25 | 2023-08-25 | AIM | AIM ImmunoTech Inc. | Equels Thomas K | CEO, Pres, Dir | P - Purchase | $0.67 | +8,222 | 584.2K | +1% | +$5,509 | |
| 2023-08-24 | 2023-08-24 | AIM | AIM ImmunoTech Inc. | Equels Thomas K | CEO, Pres, Dir | P - Purchase | $0.67 | +15.0K | 575.9K | +3% | +$10.0K | |
| 2023-07-17 | 2023-07-17 | AIM | AIM ImmunoTech Inc. | Equels Thomas K | CEO, Pres, Dir | P - Purchase | $0.59 | +16.9K | 560.9K | +3% | +$10.0K | |
| 2023-01-04 | 2023-01-03 | AIM | AIM ImmunoTech Inc. | Equels Thomas K | CEO, Pres, Dir | P - Purchase | $0.31 | +161.3K | 544.0K | +42% | +$50.0K | |
| 2022-07-18 | 2022-07-18 | AIM | AIM ImmunoTech Inc. | Equels Thomas K | CEO, Pres, Dir | A - Grant | $0.76 | +32.9K | 382.7K | +9% | +$25.0K | |
| 2022-04-26 | 2022-04-25 | AIM | AIM ImmunoTech Inc. | Equels Thomas K | CEO, Pres, Dir | A - Grant | $1.02 | +49.0K | 349.8K | +16% | +$50.0K | |
| A | 2021-12-13 | 2021-12-13 | AIM | AIM ImmunoTech Inc. | Equels Thomas K | CEO, Pres, Dir | A - Grant | $1.16 | +21.6K | 300.8K | +8% | +$25.0K |
| 2021-12-13 | 2021-12-13 | AIM | AIM ImmunoTech Inc. | Equels Thomas K | CEO, Pres | A - Grant | $1.16 | +21.6K | 300.8K | +8% | +$25.0K | |
| 2021-12-10 | 2021-12-10 | AIM | AIM ImmunoTech Inc. | Equels Thomas K | CEO, Pres | A - Grant | $1.27 | +11.8K | 279.2K | +4% | +$15.0K | |
| 2021-11-24 | 2021-11-24 | AIM | AIM ImmunoTech Inc. | EQUELS THOMAS K. | CEO, Pres, Dir | A - Grant | $1.29 | +11.6K | 267.4K | +5% | +$15.0K | |
| 2021-11-23 | 2021-11-23 | AIM | AIM ImmunoTech Inc. | EQUELS THOMAS K. | CEO, Pres, Dir | A - Grant | $1.34 | +11.2K | 255.8K | +5% | +$15.0K | |
| 2021-11-19 | 2021-11-19 | AIM | AIM ImmunoTech Inc. | EQUELS THOMAS K. | CEO, Pres, Dir | A - Grant | $1.47 | +10.2K | 244.6K | +4% | +$15.0K | |
| 2021-11-17 | 2021-11-17 | AIM | AIM ImmunoTech Inc. | EQUELS THOMAS K. | CEO, Pres, Dir | A - Grant | $1.64 | +9,146 | 234.4K | +4% | +$15.0K | |
| 2021-07-16 | 2021-07-16 | AIM | AIM ImmunoTech Inc. | EQUELS THOMAS K. | CEO, Pres, Dir | P - Purchase | $1.92 | +15.6K | 225.3K | +7% | +$30.0K |